To determine the potential clinical impact of RhoGDI2 on metastasization of HER2-amplified breast tumors, we examined mRNA expression of the gene encoding RhoGDI2, ARHGDIB, in publicly available HER2+ breast tumor datasets (N = 150, Kmplot.com). The gene discussed is ARHGDIB; the disease is breast neoplasm.